![Johannes J. P. Kastelein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Johannes J. P. Kastelein
Founder at NewAmsterdam Pharma BV
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Kastelein | M | 70 |
Dutch Atherosclerosis Society
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands.
University of Amsterdam
| - |
Jan H. Lindenbergh | M | 80 |
University of Amsterdam
| - |
Bart Staels | M | 62 |
International Atherosclerosis Society
![]() International Atherosclerosis Society Miscellaneous Commercial ServicesCommercial Services The International Atherosclerosis Society is based in Houston, TX. The private company's focus and description are not provided in the given dictionary.
European Atherosclerosis Society
| - |
Jaap Goudsmit | M | 73 |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands.
University of Amsterdam
| 35 years |
Michael Davidson | M | 67 |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | 4 years |
Jan Johansson | M | - |
European Atherosclerosis Society
| - |
Atzo Nicolaï | M | 64 |
University of Amsterdam
| - |
Douglas Kling | M | 50 |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | 3 years |
Gaurav Gupta | M | - |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | - |
Jason Robert Dinges | M | 48 |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | - |
G. J. M. van den Maagdenberg | M | 63 |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | 10 years |
Marja van Dieijen Visser | F | - |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Wim Kuijken | M | - |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Juliette Audet | F | 38 |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | - |
Erik S. G. Stroes | M | - |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Anita Nijboer | F | - |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Sander van Slootweg | M | - |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | - |
Jet Bussemaker | M | - |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Hans van Goudoever | M | - |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Mark Kramer | M | - |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Karen Kruijthof | F | - |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Chris Polman | M | - |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Willy F. de Mooij | M | - |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Theo Gevers | M | - |
University of Amsterdam
| - |
Frits A. Wijburg | M | - |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Edward H. Broekhuizen | M | - |
University of Amsterdam
| 33 years |
Cornelius A. J. Herkströter | M | 87 |
University of Amsterdam
| - |
Paul F. van der Heijden | M | 75 |
University of Amsterdam
| - |
Sjoerd E. Eisma | M | 75 |
University of Amsterdam
| - |
Leonard Hoogduin | M | 67 |
University of Amsterdam
| - |
Patrick Michael Round | M | 65 |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | - |
Steven Perrick | M | 75 |
University of Amsterdam
| - |
Hans Aerts | M | - |
University of Amsterdam
| - |
William Jonakin | M | - |
International Atherosclerosis Society
![]() International Atherosclerosis Society Miscellaneous Commercial ServicesCommercial Services The International Atherosclerosis Society is based in Houston, TX. The private company's focus and description are not provided in the given dictionary. | - |
Jaap Winter | M | 61 |
University of Amsterdam
| - |
Arnoud W. A. Boot | M | 64 |
University of Amsterdam
| 26 years |
J. J. A. Leenaars | M | 72 |
University of Amsterdam
| - |
Louise Ottilie Fresco | M | 72 |
University of Amsterdam
| 18 years |
Guillaume Jetten | M | 52 |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Bernardo Miguel Fort Brescia | M | 73 |
University of Amsterdam
| - |
Paul Smits | M | 78 |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | - |
Louis Lange | M | 72 |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | - |
Gerard Nijsten | M | - |
University of Amsterdam
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Timothy Morris | M | 62 | 9 years | |
Robert Wilson | M | 83 | 1 years | |
Michael Astrue | M | 67 | 1 years | |
Peter Y. Tam | M | 60 | 20 years | |
David Norton | M | 72 | 7 years | |
Mark B. Logan | M | 84 | 15 years | |
Deborah Larsen | F | - | - | |
Anthony Zook | M | 63 | - | |
Seth Fischer | M | 68 | 4 years | |
Sam Colin | M | 59 | 2 years | |
Linda M. Dairiki Shortliffe | M | 75 | 14 years | |
Leland F. Wilson | M | 80 | 22 years | |
Alexander Denner | M | 54 | 2 years | |
Charles Casamento | M | 78 | 5 years | |
Ernest Mario | M | 85 | 1 years | |
J. Carroll | M | 74 | 1 years | |
Tracy Guo | F | - | - | |
Lee B. Perry | M | 73 | 8 years | |
Barbara Troupin | M | 56 | 8 years | |
Sandra E. Wells | M | - | - | |
Michael Miller | M | 67 | 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
Netherlands | 40 | 62.50% |
United States | 23 | 35.94% |
Sweden | 2 | 3.13% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Johannes J. P. Kastelein
- Personal Network